SEC Form 4 · accession 0001209191-17-046037
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shamim Ruff
Officer — SVP, Regulatory Affairs & Qual
Period of report
Jul 20, 2017
Accepted (ET)
Jul 21, 2017 · 9:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 20, 2017 | M | 6,250 | $13.71 | A | 27,312 | D | |
| Common StockF1 | Jul 20, 2017 | S | 6,250 | $42.00 | D | 21,062 | D | |
| Common StockF1 | Jul 21, 2017 | M | 4,388 | $13.90 | A | 25,450 | D | |
| Common StockF1 | Jul 21, 2017 | S | 4,388 | $44.00 | D | 21,062 | D | |
| Common StockF1 | Jul 21, 2017 | M | 1,500 | $14.76 | A | 22,562 | D | |
| Common StockF1 | Jul 21, 2017 | S | 1,500 | $44.00 | A | 21,062 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (right to buy)F1 | $13.71 | Jul 20, 2017 | M | 6,250 | D | Feb 28, 2017 | Feb 28, 2026 | Common Stock | 6,250 | 17,708 | D |
| Non-Qualified Stock Options (right to buy)F1 | $13.90 | Jul 21, 2017 | M | 4,388 | D | Feb 27, 2016 | Feb 27, 2025 | Common Stock | 4,388 | 5,098 | D |
| Incentive Stock Option (right to buy)F1 | $14.76 | Jul 21, 2017 | M | 1,500 | D | May 6, 2015 | May 6, 2025 | Common Stock | 1,500 | 52,644 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 12, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.